Research Article
[Retracted] Effect of Autoimmune Cell Therapy on Immune Cell Content in Patients with COPD: A Randomized Controlled Trial
Table 1
Inclusion and exclusion criteria and abort test standard.
| | Project | |
| | Inclusion criteria | after inhalation of bronchodilators, except for other diseases causing incomplete reversible airflow obstruction | | 45-80 years old | | Patients without other major diseases, history of allergies, and genetic history | | Signed informed consent |
| | Exclusion criteria | Patients with chronic cough and wheezing caused by tuberculosis, tumor, irritant gas allergy etc. | | Patients complicated with cardiovascular, liver, kidney, hematopoietic system, and other serious primary diseases | | Patients with abnormal behavior or mental illness | | Allergic people | | Patients with communication barriers | | Patients with acute aggravation within 3 months of treatment | | Suffer from other major diseases and were allergic to the drugs used in this study | | Patients without using the drug as prescribed | | Those whose efficacy or safety judgment was affected by incomplete data |
| | Abort test standard | Patients with severe adverse reactions or special physiological changes | | Patients with life-threatening |
|
|